checkAd

    Dexcom G7 Receives FDA Clearance  143  0 Kommentare The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S. - Seite 2

    • No fingersticks, scanning or calibration
    • Real-time glucose readings sent automatically every 5 minutes to a compatible display device*
    • Integration with the world’s largest connected CGM ecosystem (including Apple Watch, Garmin and other digital health apps)*
    • Remote monitoring, enabling users to share glucose data with up to 10 followers#
    • Proven Dexcom accuracy and performance5
    • Only CGM to offer a predictive low alert that can recognize potentially dangerous hypo-incidences before they occur

     

    Dexcom is working closely with its insulin pump partners to integrate Dexcom G7 into current and future automated insulin delivery systems as quickly as possible.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Dexcom!
    Long
    114,04€
    Basispreis
    1,55
    Ask
    × 7,79
    Hebel
    Short
    152,01€
    Basispreis
    2,30
    Ask
    × 5,70
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Proven performance with easy-to-use, customizable features

    With Dexcom G7, the most recommended CGM brand among patients6 and healthcare providers7 now offers a more powerful and easier to use system with a small, all-in-one wearable, completely redesigned mobile app and no fingersticks or scanning required. Dexcom G7 also offers a suite of customizable alerts that can warn of high or low glucose levels and help users spend more time in range.**,2 The system features a predictive low alert that provides a 20-minute advance warning of potentially dangerous low glucose levels so users can act quickly to avoid a hypoglycemic event. This critical feature continues to be at the forefront of the Dexcom experience, with more than 52 million Urgent Low Soon alerts acknowledged – more than 11 million of those in the middle of the night.1Users can also share information with loved ones and care teams anywhere, anytime through industry-leading remote monitoring and reporting capabilities.# These features, among others, helped Dexcom G7 earn recognition as a CES 2023 innovation awards honoree in the wearable technology, digital health category.

    “The first thing that stood out to me when I started using the Dexcom CGM was how easy it was to use,” said Zac Harmon, a Dexcom Warrior and blues musician. “It’s small, non-intrusive and has been the biggest part of my diabetes journey. It feels like it was made just for me, so I can focus more on what’s really important in my life.”

    With the most coverage,4 more users pay less for the #1 preferred CGM6,7

    As diabetes becomes increasingly prevalent, it’s more important than ever for all people with diabetes to have access to the best care and technology.

    Seite 2 von 4



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Dexcom G7 Receives FDA Clearance The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S. - Seite 2 DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the FDA has cleared the next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with all Types …